Terminated NA INTERVENTIONAL 1-arm NCT02130401

Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes

Sponsor: Scion NeuroStim

Interventions TNM Device

Updated 7 times since 2017 Last updated: May 19, 2025 Started: Jun 30, 2014 Primary completion: May 31, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Poor enrollment (15 planned, only 6 enrolled)

Other terminated trials from Scion NeuroStim

More terminations from Scion NeuroStim

Other Type 2 Diabetes trials with similar outcome

Browse all Type 2 Diabetes trials

Listed as NCT02130401, this NA trial focuses on Type 2 Diabetes and remains terminated or withdrawn. Sponsored by Scion NeuroStim, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jul 2025 — Present [monthly]

Terminated NA

Status: Completed → Terminated
Sep 2024 — Jul 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Scion NeuroStim

Data source: Scion NeuroStim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chapel Hill, United States